highly significantP <.001
marginally significantP =.046
For pharmaceutical expenditure, the fall in slope for test patients was highly significant ( P <.001), while control patients showed a marginally significant ( P =.046) increase in slope.
For pharmaceutical expenditure, the fall in slope for test patients was highly significant ( P <.001), while control patients showed a marginally significant ( P =.046) increase in slope.